|
1
|
Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
|
J Clin Oncol
|
2008
|
2.08
|
|
2
|
Outcome of allogeneic stem cell transplantation in children with non-malignant diseases.
|
Haematologica
|
2006
|
1.47
|
|
3
|
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?
|
J Clin Oncol
|
2004
|
1.39
|
|
4
|
Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR.
|
Br J Haematol
|
2005
|
1.35
|
|
5
|
CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties.
|
Haematologica
|
2010
|
1.30
|
|
6
|
Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation.
|
Blood
|
2011
|
1.16
|
|
7
|
Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation.
|
Haematologica
|
2010
|
1.06
|
|
8
|
The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells.
|
Cytotherapy
|
2011
|
1.04
|
|
9
|
Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia.
|
Br J Haematol
|
2003
|
1.00
|
|
10
|
IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study.
|
PLoS One
|
2011
|
0.97
|
|
11
|
Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia.
|
Br J Haematol
|
2005
|
0.93
|
|
12
|
Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models.
|
Front Oncol
|
2012
|
0.90
|
|
13
|
Sequence polymorphism systems for quantitative real-time polymerase chain reaction to characterize hematopoietic chimerism-high informativity and sensitivity as well as excellent reproducibility and precision of measurement.
|
Lab Hematol
|
2007
|
0.83
|
|
14
|
Analysis of chimerism after stem cell transplantation.
|
Methods Mol Med
|
2004
|
0.79
|
|
15
|
Pitfalls in detection of contaminating neuroblastoma cells by tyrosine hydroxylase RT-PCR due to catecholamine-producing hematopoietic cells.
|
Anticancer Res
|
2006
|
0.78
|
|
16
|
Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy.
|
Br J Haematol
|
2005
|
0.77
|
|
17
|
Detection of relapse after hematopoietic stem cell transplantation in childhood by monitoring of WT1 expression and chimerism.
|
J Cancer Res Clin Oncol
|
2015
|
0.77
|
|
18
|
Absence of Maternal Microchimerism in Regional Lymph Nodes of Children With Biliary Atresia.
|
J Pediatr Gastroenterol Nutr
|
2016
|
0.77
|
|
19
|
Examining the origin of posttransplant lymphoproliferative disorder in a patient after a second allogeneic hematopoeitic stem cell transplantation for relapsed BCR-ABL positive acute lymphoblastic leukemia.
|
J Pediatr Hematol Oncol
|
2011
|
0.76
|
|
20
|
NOD2/CARD15 gene polymorphisms affect outcome in pediatric allogeneic stem cell transplantation.
|
Blood
|
2011
|
0.76
|
|
21
|
WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?
|
Eur J Haematol
|
2004
|
0.75
|